Company intelligence / Profile preview

Dongwha Pharmaceutical Co., Ltd.

Seoul, South Koreadong-wha.co.kr ↗
Ownership
Private
Employees
~816
Development stage
Preclinical
01

Overview

Dongwha Pharmaceutical has multiple approved drugs including DW-166HC for Hemophilia A, Dapagliflozin/Sitagliptin for Type 2 Diabetes, Zabofloxacin D-aspartate for Respiratory Tract Infections, Loxoprofen Sodium Hydrate for Pain, and Choline Alfoscerate for Cognition Disorders[9]. The company is also developing new treatments including a sarcopenia treatment in collaboration with Animuscure[6].

Therapeutic areas
Metabolic DisordersPulmonologyEndocrinologyOncologyImmunologyHematologyNeurologyInfectious Diseases
Modalities
Small molecule drugsBiological productsTherapeutic radiopharmaceuticalsFixed-dose combinationsProbiotics
Industry
Biotech
02

Drug pipeline

17 assets

zabofloxacin

3

16 more assets in the full pipeline.

Request access →
03

Partnerships

Animuscure (for sarcopenia treatment development)[6]Previously had partnership with GSK Consumer Healthcare Korea (ended)[8]

Beyond the preview

Go deeper on Dongwha Pharmaceutical Co., Ltd..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dongwha Pharmaceutical Co., Ltd..

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call